LYCOS RETRIEVER Beta Retriever Home  |  What is Lycos Retriever?   
Pharmaceuticals: New York
built 213 days ago
KNOXVILLE, Tenn., Dec. 18, 2006 (PRIME NEWSWIRE) -- Craig Dees, CEO, of Provectus Pharmaceuticals, Inc. (OTCBB: PVCT - News), will be featured live on Market News First (http://www.MN1.com) for an exclusive interview with the MN1 news team. The interview is scheduled for Dec. 19, 2006, at 10:00AM CDT.
Source:
Javelin Pharmaceuticals Logo CAMBRIDGE, Mass., Feb. 10 /PRNewswire-FirstCall/ -- Javelin Pharmaceuticals, Inc. (OTC Bulletin Board: JVPH.OB - News) announced today that Douglas A. Hamilton, Chief Operating Officer and Chief Financial Officer, will be returning to the venture capital community. Mr. Hamilton will remain in his position until a successor is named, and will continue as CFO through completion of the fiscal year-end 2005 financial reports.
GAITHERSBURG, MD, December 10, 2004 /PRNewswire/ -- Panacos Pharmaceuticals, Inc. today announced the initiation of a Phase 2a clinical trial of PA-457, the first in a new class of HIV drug candidates called Maturation Inhibitors. Institutional Review Board (IRB) and other approvals have been received and the study is now open for enrollment. Panacos plans to complete dosing of all patients during Q1, 05.
Source:
Pharmaceuticals are playing an increasingly important role in Canadians' health and Canada's health care system. They save lives, prevent the spread of disease, improve the quality of life for many, and control pain and suffering. Their role is likely to grow in the future as technological advances result in new drug therapies that replace earlier treatment methods or provide new options where no treatment existed before.
Source:
NEW YORK, NY OCT 12, 2006 - Manhattan Pharmaceuticals, Inc. (AMEX: MHA) today announced expansion of its oral Oleoyl-estrone (OE) clinical obesity program to include the morbidly obese. A new US Phase 2a clinical trial evaluating oral OE in morbidly obese male subjects will be initiated in October 2006.
KNOXVILLE, Tenn.--June 19, 2003�-Provectus Pharmaceuticals, Inc.(BULLETIN BOARD: PVCT - News) today announced an international distribution agreement for its antibacterial hand cleanser with Kevork Instruments of Monterrey, Mexico. Kevork will be the exclusive distributor of Provectus' Pure-ific(TM) antibacterial hand spray in Mexico and Central America.
Source:
SEARCH
MORE ABOUT